Double-blind, randomized, parallel design study comparing effectiveness of losartan vs. hydrochlorothiazide in reversing or preventing the progression of the remodeling of resistance arteries in pre-hypertensive pre-diabetic subjects

Trial Profile

Double-blind, randomized, parallel design study comparing effectiveness of losartan vs. hydrochlorothiazide in reversing or preventing the progression of the remodeling of resistance arteries in pre-hypertensive pre-diabetic subjects

Discontinued
Phase of Trial: Phase I

Latest Information Update: 22 May 2015

At a glance

  • Drugs Losartan (Primary) ; Hydrochlorothiazide
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 22 May 2015 Last checked against the ClinicalTrials.gov record.
    • 06 Oct 2009 Planned end date (1 Dec 2009) added as reported by ClinicalTrials.gov.
    • 06 Oct 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top